NGM Bio has filed a notice of an exempt offering of securities to raise $122,039,949.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, NGM Bio is raising up to $122,039,949.00 in new funding. Sources indicate that as part of senior management Chairman and Chief Executive Officer, David Goeddel…